Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yissum Research Development Company of the Hebrew University of Jerusalem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10818
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university’s faculty, staff, researchers, and students. Its products include exelon, doxil, cherry tomatoes and long shelf-life tomatoes, granagard, osmoter x6 facial serum, hybrid peppers, hygia nutrients, artichoke, cationorm, agcite, vuze, melon, periochip, ikervis, explora, superior ceramic ink, uv-pearl, seer, and bioresorbable adhesion barrier. YRDC transfers the technologies in various fields including computer science, medicine and pharmaceuticals, nanotechnology, water and environmental technologies, agriculture and nutrition, homeland security, and others. The company supports business partners in identifying the researcher to conduct the research and tailor the partnerships to the requirements of the business partner and the technologies. YRDC is headquartered in Jerusalem, Israel.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Partnerships 21
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
Licensing Agreements 25
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Acquisition 36
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Subsidiaries 39

List of Figures
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ConceptoMed AS:医療機器:M&Aディール及び事業提携情報
    Summary ConceptoMed AS (ConceptoMed) is a medical device company that offers medtech systems. The company offers Luer-Jack, a medical syringe facilitating safer conditions for performing medical procedures. Its Luer-Jack provides superior usability advantages, preventing dislodging of the sharp need …
  • InvitroCue Ltd (IVQ):企業の財務・戦略的SWOT分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image a …
  • PeriGen Inc-医療機器分野:企業M&A・提携分析
    Summary PeriGen Inc (PeriGen), formerly E&C Medical Intelligence Inc is a healthcare technology company that offers advanced obstetric decision-support systems. The company offers fetal monitoring systems which include tracings, patterns, curve and shoulder screen systems. Its decision-support softw …
  • Tieto Corp (TIETO):企業の財務・戦略的SWOT分析
    Tieto Corp (TIETO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • House Foods Group Inc:企業の戦略・SWOT・財務分析
    House Foods Group Inc - Strategy, SWOT and Corporate Finance Report Summary House Foods Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • GlaxoSmithkline Consumer Healthcare Ltd:企業の戦略・SWOT・財務情報
    GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析
    Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report Summary Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Mechel:企業の戦略・SWOT・財務情報
    Mechel - Strategy, SWOT and Corporate Finance Report Summary Mechel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • mixi, Inc.:企業の戦略・SWOT・財務分析
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ScinoPharm Taiwan Ltd (1789):製薬・医療:M&Aディール及び事業提携情報
    Summary ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry. It services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for th …
  • Pearl Global Industries Limited:企業の戦略・SWOT・財務情報
    Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Kilitch Drugs India Ltd (KILITCH)-製薬・医療分野:企業M&A・提携分析
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as carbapenems, cephalosporins, beta-lactam antibiotics, steroids and hormones, gastrology and …
  • Abionic SA-医療機器分野:企業M&A・提携分析
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company offers products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone & iPad, and accessories. Its abioSCOPE in vitro tests are design …
  • Merus Labs International Inc (MSL):企業の財務・戦略的SWOT分析
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆